KR20160136982A - Composition for Hair growth promotion and Hair loss prevention and Manufacturing Method thereof - Google Patents
Composition for Hair growth promotion and Hair loss prevention and Manufacturing Method thereof Download PDFInfo
- Publication number
- KR20160136982A KR20160136982A KR1020150071415A KR20150071415A KR20160136982A KR 20160136982 A KR20160136982 A KR 20160136982A KR 1020150071415 A KR1020150071415 A KR 1020150071415A KR 20150071415 A KR20150071415 A KR 20150071415A KR 20160136982 A KR20160136982 A KR 20160136982A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- group
- concentrate
- natural
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 230000003779 hair growth Effects 0.000 title claims abstract description 42
- 230000003658 preventing hair loss Effects 0.000 title claims abstract description 34
- 238000004519 manufacturing process Methods 0.000 title description 12
- 239000003814 drug Substances 0.000 claims abstract description 78
- 239000012141 concentrate Substances 0.000 claims abstract description 76
- 229940079593 drug Drugs 0.000 claims abstract description 64
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 52
- 230000001737 promoting effect Effects 0.000 claims abstract description 35
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000007787 solid Substances 0.000 claims abstract description 23
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 21
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims abstract description 19
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims abstract description 19
- 229940010454 licorice Drugs 0.000 claims abstract description 19
- 244000194101 Ginkgo biloba Species 0.000 claims abstract description 13
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 11
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 11
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 10
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 10
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims abstract description 9
- 240000008397 Ganoderma lucidum Species 0.000 claims abstract description 9
- 235000011201 Ginkgo Nutrition 0.000 claims abstract description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 4
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 4
- 235000008397 ginger Nutrition 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 36
- 238000000605 extraction Methods 0.000 claims description 20
- 230000008569 process Effects 0.000 claims description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 16
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 16
- 235000008434 ginseng Nutrition 0.000 claims description 16
- 230000032683 aging Effects 0.000 claims description 15
- 235000009754 Vitis X bourquina Nutrition 0.000 claims description 10
- 235000012333 Vitis X labruscana Nutrition 0.000 claims description 10
- 240000006365 Vitis vinifera Species 0.000 claims description 10
- 235000014787 Vitis vinifera Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 244000061508 Eriobotrya japonica Species 0.000 claims description 8
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 8
- 241000508269 Psidium Species 0.000 claims description 8
- 235000002248 Setaria viridis Nutrition 0.000 claims description 6
- 244000230342 green foxtail Species 0.000 claims description 6
- 241000003910 Baronia <angiosperm> Species 0.000 claims description 4
- 235000009467 Carica papaya Nutrition 0.000 claims description 3
- 240000006432 Carica papaya Species 0.000 claims description 3
- 229940107131 ginseng root Drugs 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 240000002234 Allium sativum Species 0.000 claims description 2
- 235000004611 garlic Nutrition 0.000 claims description 2
- 241000202807 Glycyrrhiza Species 0.000 claims 4
- 241000208340 Araliaceae Species 0.000 claims 3
- 240000004670 Glycyrrhiza echinata Species 0.000 abstract 2
- 210000004209 hair Anatomy 0.000 description 44
- 230000000694 effects Effects 0.000 description 18
- 244000303040 Glycyrrhiza glabra Species 0.000 description 15
- 201000004384 Alopecia Diseases 0.000 description 14
- 210000004761 scalp Anatomy 0.000 description 14
- 240000004371 Panax ginseng Species 0.000 description 13
- 230000017531 blood circulation Effects 0.000 description 13
- 230000003676 hair loss Effects 0.000 description 13
- 239000000843 powder Substances 0.000 description 13
- 208000024963 hair loss Diseases 0.000 description 12
- 238000009472 formulation Methods 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- -1 Acubin Chemical compound 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 230000001256 tonic effect Effects 0.000 description 8
- 239000002453 shampoo Substances 0.000 description 7
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000012010 growth Effects 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 6
- 229930182490 saponin Natural products 0.000 description 6
- 150000007949 saponins Chemical class 0.000 description 6
- 238000001914 filtration Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 238000003809 water extraction Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 235000013824 polyphenols Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 238000002604 ultrasonography Methods 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 235000008708 Morus alba Nutrition 0.000 description 3
- 240000000249 Morus alba Species 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 241000219784 Sophora Species 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000003859 lipid peroxidation Effects 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- 235000005254 Allium ampeloprasum Nutrition 0.000 description 2
- 240000006108 Allium ampeloprasum Species 0.000 description 2
- 235000018865 Angelica gigas Nutrition 0.000 description 2
- 240000001810 Angelica gigas Species 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 235000013527 bean curd Nutrition 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000002768 hair cell Anatomy 0.000 description 2
- 230000009583 hair follicle growth Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 235000021268 hot food Nutrition 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 235000005152 nicotinamide Nutrition 0.000 description 2
- 239000011570 nicotinamide Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229940117382 propecia Drugs 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002374 sebum Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000010865 sewage Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 1
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 1
- XFZJEEAOWLFHDH-UHFFFAOYSA-N (2R,2'R,3R,3'R,4R)-3,3',4',5,7-Pentahydroxyflavan(48)-3,3',4',5,7-pentahydroxyflavan Natural products C=12OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C(O)C=C(O)C=1C(C1=C(O)C=C(O)C=C1O1)C(O)C1C1=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-UHFFFAOYSA-N 0.000 description 1
- XUCIJNAGGSZNQT-JHSLDZJXSA-N (R)-amygdalin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O[C@@H](C#N)C=2C=CC=CC=2)O1 XUCIJNAGGSZNQT-JHSLDZJXSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- QIIDATRCGITYRZ-UHFFFAOYSA-N Catalpol Natural products OCC1OC(OC2OC=CC3C(O)C(=C(CO)C23)O)C(O)C(O)C1O QIIDATRCGITYRZ-UHFFFAOYSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 1
- 241000212948 Cnidium Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000587240 Cynanchum Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- 240000000691 Houttuynia cordata Species 0.000 description 1
- 235000013719 Houttuynia cordata Nutrition 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 description 1
- 241000036312 Juniperus coahuilensis Species 0.000 description 1
- 241000218194 Laurales Species 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- QZXSMBBFBXPQHI-UHFFFAOYSA-N N-(dodecanoyl)ethanolamine Chemical compound CCCCCCCCCCCC(=O)NCCO QZXSMBBFBXPQHI-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PDHAOJSHSJQANO-OWOJBTEDSA-N Oxyresveratrol Chemical compound OC1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 PDHAOJSHSJQANO-OWOJBTEDSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- XFZJEEAOWLFHDH-HNTGQZGLSA-N Procyanidin B3 Natural products C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@@H]([C@@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-HNTGQZGLSA-N 0.000 description 1
- 229920000236 Procyanidin B3 Polymers 0.000 description 1
- 235000011158 Prunus mume Nutrition 0.000 description 1
- 244000018795 Prunus mume Species 0.000 description 1
- 244000236580 Psidium pyriferum Species 0.000 description 1
- 235000013929 Psidium pyriferum Nutrition 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- 235000000656 Rosa multiflora Nutrition 0.000 description 1
- 244000050053 Rosa multiflora Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 235000004338 Syringa vulgaris Nutrition 0.000 description 1
- 244000297179 Syringa vulgaris Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- PPWHTZKZQNXVAE-UHFFFAOYSA-N Tetracaine hydrochloride Chemical compound Cl.CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 PPWHTZKZQNXVAE-UHFFFAOYSA-N 0.000 description 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 description 1
- 240000006023 Trichosanthes kirilowii Species 0.000 description 1
- 206010047141 Vasodilatation Diseases 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- LHDWRKICQLTVDL-PZYDOOQISA-N catalpol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2[C@@]3(CO)O[C@H]3[C@@H](O)[C@@H]2C=CO1 LHDWRKICQLTVDL-PZYDOOQISA-N 0.000 description 1
- UXSACQOOWZMGSE-UHFFFAOYSA-N catalposide Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(OC(=O)C=3C=CC(O)=CC=3)C2C=CO1 UXSACQOOWZMGSE-UHFFFAOYSA-N 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004129 fatty acid metabolism Effects 0.000 description 1
- 235000021149 fatty food Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 1
- 229940011656 madecassic acid Drugs 0.000 description 1
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- LHDWRKICQLTVDL-UHFFFAOYSA-N methyl iridoid glycoside Natural products OC1C(O)C(O)C(CO)OC1OC1C2C3(CO)OC3C(O)C2C=CO1 LHDWRKICQLTVDL-UHFFFAOYSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 208000003154 papilloma Diseases 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- XFZJEEAOWLFHDH-AVFWISQGSA-N procyanidin B3 Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(O)C=C(O)C=C3O2)C=2C(O)=CC(O)=C3C[C@@H]([C@H](OC3=2)C=2C=C(O)C(O)=CC=2)O)=CC=C(O)C(O)=C1 XFZJEEAOWLFHDH-AVFWISQGSA-N 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 1
- 235000015500 sitosterol Nutrition 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940057950 sodium laureth sulfate Drugs 0.000 description 1
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 230000000304 vasodilatating effect Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/27—Asclepiadaceae (Milkweed family), e.g. hoya
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 탈모방지 및 발모촉진용 조성물 및 그 제조방법에 관한 것으로서, 본 발명에 따른 탈모방지 및 발모촉진용 조성물은 고형분이 40 ~ 60%인 홍삼농축액 1중량부와; 하수오 10 ~ 20중량부, 영실근 10 ~ 20중량부, 고삼 10 ~ 20중량부, 건지황 5 ~ 15중량부, 당귀 5 ~ 10중량부, 천궁 5 ~ 10중량부, 감초 1 ~ 5중량부로부터 얻은 고형분이 40 ~ 60%인 제1그룹천연약제농축액 4 ~ 5중량부와; 한련초 15 ~ 30중량부, 어성초 15 ~ 30중량부, 구절초 15 ~ 20중량부, 측백엽 5~ 10중량부, 은행잎 5 ~ 10중량부, 병풀잎 5 ~ 10중량부로부터 얻은 고형분이 40 ~ 60%인 제2그룹천연약제농축액 2~ 5중량부를 포함하는 것을 특징으로 한다. 이에 의해, 탈모방지 및 발모촉진효과가 향상된다.The present invention relates to a composition for preventing hair loss and promoting hair growth and a method for preparing the same, wherein the composition for preventing hair loss and promoting hair growth comprises 1 part by weight of a red ginseng concentrate having a solid content of 40 to 60% 10 to 20 parts by weight of Sasao, 10 to 20 parts by weight of Ganoderma lucidum, 10 to 20 parts by weight of Ganoderma lucidum, 5 to 15 parts by weight of dried ginger, 5 to 10 parts by weight of Ganoderma lucidum, 5 to 10 parts by weight of licorice and 1 to 5 parts by weight of licorice 4 to 5 parts by weight of a concentrated concentrate of the first group of natural medicines having a solid content of 40 to 60% 15 to 30 parts by weight of persimmon, 15 to 30 parts by weight of persimmon, 15 to 20 parts by weight of persimmon, 5 to 10 parts by weight of a lateral leaf, 5 to 10 parts by weight of a ginkgo leaf, and 5 to 10 parts by weight of a bottle, And 2 to 5 parts by weight of a second group of natural agent concentrates. Thus, hair loss prevention and hair growth promoting effect are improved.
Description
본 발명은 탈모방지 및 발모촉진용 조성물 및 그 제조방법에 관한 것으로서, 보다 상세하게는 모발이 비정상적으로 많이 탈락하는 것을 방지하거나 모발의 재생을 촉진시키는 데 사용되는 탈모방지 및 발모촉진용 조성물에 관한 것이다.The present invention relates to a composition for preventing hair loss and promoting hair growth, and more particularly, to a composition for preventing hair loss and promoting hair growth, which is used for preventing hair from dropping off abnormally abnormally or promoting hair regeneration will be.
모발은 작은 찰과상과 자외선으로부터 상피조직을 보호하고, 외부로부터의 자극을 전달하며, 체온을 조절하는 등의 중요한 기능을 갖는다. 특히 두피모발 (scalp hair)은 인체 모발의 약 20%를 차지하는데, 모발의 생리적 기능과 함께 두부의 완충작용으로 두부를 충격으로부터 보호할 뿐 아니라 성별, 연령 및 지위에 따른 개인의 개성과 긍정적인 이미지를 부여하는 등의 사회적으로 중요한 기능을 갖는다.Hair has important functions such as protecting the epithelial tissue from small abrasions and ultraviolet rays, transmitting external stimuli, and controlling body temperature. In particular, scalp hair accounts for about 20% of the human hair. It is not only protects the tofu from impact by buffering the tofu along with the physiological function of the hair, but also protects the individual personality by sex, age and position, Image, and so on.
모발은 생장기, 퇴행기 및 휴지기를 반복하는데, 정상적인 두피에서 90 ~ 95%는 생장기에 있고 1% 미만은 퇴화기에 있으며 5 ~ 10%는 휴지기에 있으며, 매일 100개 이상의 모발이 휴지기에 접어들고 같은 수의 모낭은 다시 생장기로 들어간다.The hair repeats the growth, regrowth, and pauses. In the normal scalp, 90-95% is in the growth phase, less than 1% is in the regenerator, 5 ~ 10% is in the resting period, more than 100 hairs are folded daily, The hair follicles enter the growth again.
이러한 성장주기를 거치는 모발이 비정상적으로 많이 탈락되거나 재생되지 않는 증상을 탈모(alopecia)라 한다.Alopecia is a condition in which abnormal hair is not removed or regenerated through such a growth cycle.
탈모는 노화현상으로 알려져 왔으나 유전적 요인, 스트레스, 식생활 식습관 등 다양한 요인이 작용하여 나타나기도 하는 것으로 알려져 있다.Hair loss has been known to be an aging phenomenon, but it is known that a variety of factors such as genetic factors, stress, and eating habits may act.
탈모는 사람에게 모발의 생리적 기능을 상실시킬 뿐 아니라 자부심 감소, 정신적 고통, 부끄러움 및 사회적 부족감 등의 정서적 내지 정신적인 영향을 미쳐 사회성을 떨어뜨리는 심각한 요인으로 작용하므로, 탈모를 예방하거나 치료할 수 있는 약제가 안출되어 사용되고 있다.Hair loss not only loses the physiological function of hair to a person but also affects the emotional and mental effects of reduced self-esteem, mental suffering, shame, and social insufficiency, and acts as a serious factor that deteriorates sociality. Thus, Have been used.
종래 탈모의 예방 또는 치료제로는 경피 도포제로서 미녹시딜 (Minoxidil)과 경구 복용제로서 프로페시아(Propecia)가 널리 사용되고 있었지만, 이들 약제들에 포함된 화학성분에 의해 가려움증, 홍반, 표피 벗겨짐, 피부염, 남성 성기능 장애 등의 심각한 부작용을 초래하여 장기적으로 사용하기에 적합하지 않다는 문제점이 있었다.Minoxidil has been widely used as a transdermal application agent and Propecia has been widely used as a prophylactic or therapeutic agent for hair loss. However, due to the chemical components contained in these medicines, itching, erythema, peeling of the epidermis, It has a problem that it is not suitable for long-term use because it causes serious side effects such as disorder.
전술한 미녹시딜 또는 프로페시아의 문제점을 해결하기 위해 천연약제추출물(생약재 추출물)을 사용하는 발모약제가 안출되어 사용되고 있다.In order to solve the problems of the above-mentioned minoxidil or propecia, hair growth drugs using a natural drug extract (herbal medicine extract) have been used.
종래 천연약제추출물을 사용하는 발모약제는 특허공개공보 제10-2009-0051586호(가시오가피, 송엽, 송화, 교맥, 생지황 및 지모 사용), 특허공개공보 제10-2005-0014473호(백두옹, 대산, 황금 사용), 특허등록공보 제10-1445553호(감초, 구기자, 하수오, 하늘타리, 홍삼 및 은행잎 사용, 등록일자 2014년 9월 23일)등에 개시되어 있다.Conventional hair growth agents using natural pharmaceutical extracts are disclosed in Patent Publication No. 10-2009-0051586 (Katsushiro, Kyoji, Songhwa, Kyoemaku, Kiyomi, and Kiyomi), Patent Publication No. 10-2005-0014473 (Baekjeong, Daesan, ), Patent Registration No. 10-1445553 (Licorice, Gugija, Hassuo, Chukta-ri, use of red ginseng and ginko leaves, date of registration September 23, 2014).
이하 특허등록공보 제10-1445553호에 개시된 발모약제(이하 "종래의 탈모방지 및 발모촉진용 조성물"이라고 함)에 설명하기로 한다.Hereinafter, the hair growth inhibitor disclosed in Patent Registration No. 10-1445553 (hereinafter referred to as "conventional hair loss prevention and hair growth promoting composition") will be described.
종래의 탈모방지 및 발모촉진용 조성물은, 감초 2~5중량부, 구기자 2~5중량부, 하수오 4~10중량부, 하늘타리 2~5중량부, 홍삼 2~5중량부 및 은행잎 2~5중량부를 생약추출물 0.1~10.0%와, 비오틴, 징크피리치온, 니코틴산아미드 및 덱스판테놀의 복합 조성물을 포함하고 있다.The conventional composition for preventing hair loss and hair growth includes 2 to 5 parts by weight of licorice, 2 to 5 parts by weight of ginger, 4 to 10 parts by weight of sewage, 2 to 5 parts by weight of fowl, 2 to 5 parts by weight of red ginseng, And 0.1 to 10.0% of herbal extract, and a composite composition of biotin, zinc pyritic acid, nicotinic acid amide and dexpanthenol.
생약추출물은 알코올 추출 또는 열수 추출하여 얻는다.Herbal medicine extracts are obtained by alcohol extraction or hot water extraction.
그런데 종래의 탈모방지 및 발모촉진용 조성물에 따르면, 하수오 (Cynanchum silfordii Hemsley)의 항산화작용, 감초(Glycyrrhiza glabra)의 항염증 및 항균효과, 하늘타리(Trichosanthes Kirilowii L., 과루인)의 항염증효과, 구기자의 흑발효과(두발이 검고 윤택해지는 효과), 홍삼의 모모세포의 부활효과(기능이 저하된 모모세포를 부활시켜 발모나 모발의 성장을 촉진함), 은행잎의 항산화작용 및 항균효과에 의해 탈모를 방지하고 발모를 촉진하게 되지만 탈모방지 또는 발모촉진을 위해 필요한 혈관확장 및 혈류촉진, 두피 자극작용, 피지분비 억제, 모모세포의 부활, 영양보급, 항염증 작용이 충분하지 못해 탈모방지 및 발모촉진효과가 제한적이라는 문제점이 있었다. However, according to the composition for preventing hair loss and hair growth, antioxidative action of Cynanchum silfordii Hemsley, anti-inflammatory and antibacterial effect of Glycyrrhiza glabra, anti-inflammatory effect of Trichosanthes Kirilowii L., The effect of redness of Gugija (the effect of darkening hair), the resurrection effect of red ginseng monocytes (promoting the growth of hair and hair by revitalizing the hair cells whose functions are deteriorated), and the antioxidative and antimicrobial effects of Ginkgo biloba And promotes hair growth. However, it does not have enough hair growth enhancement and blood flow promotion, scalp stimulation action, suppression of sebum secretion, resurrection of monocyte, nutrient supply and anti-inflammatory action necessary for preventing hair loss or promoting hair growth, The effect is limited.
따라서 본 발명의 목적은, 탈모방지 및 발모촉진효과가 향상된 탈모방지 및 발모촉진용 조성물 및 그 제조방법을 제공하는 것이다.Accordingly, an object of the present invention is to provide a composition for preventing hair loss and for promoting hair growth with improved hair loss prevention and hair growth promoting effect, and a method for producing the same.
상기 목적은, 본 발명에 따라, 고형분이 40 ~ 60%인 홍삼농축액 1중량부와;According to the present invention, the above-mentioned object is achieved by a process for producing a red ginseng concentrate, comprising: 1 part by weight of a red ginseng concentrate having a solid content of 40 to 60%
하수오 10 ~ 20중량부, 영실근 10 ~ 20중량부, 고삼 10 ~ 20중량부, 건지황 5 ~ 15중량부, 당귀 5 ~ 10중량부, 천궁 5 ~ 10중량부, 감초 1 ~ 5중량부로부터 얻은 고형분이 40 ~ 60%인 제1그룹천연약제농축액 4 ~ 5중량부와; 한련초 15 ~ 30중량부, 어성초 15 ~ 30중량부, 구절초 15 ~ 20중량부, 측백엽 5~ 10중량부, 은행잎 5 ~ 10중량부, 병풀잎 5 ~ 10중량부로부터 얻은 고형분이 40 ~ 60%인 제2그룹천연약제농축액 2~ 5중량부를 포함하는 것을 특징으로 하는 탈모방지 및 발모촉진용 조성물에 의해 달성된다.10 to 20 parts by weight of Sasao, 10 to 20 parts by weight of Ganoderma lucidum, 10 to 20 parts by weight of Ganoderma lucidum, 5 to 15 parts by weight of dried ginger, 5 to 10 parts by weight of Ganoderma lucidum, 5 to 10 parts by weight of licorice and 1 to 5 parts by weight of licorice 4 to 5 parts by weight of a concentrated concentrate of the first group of natural medicines having a solid content of 40 to 60% 15 to 30 parts by weight of persimmon, 15 to 30 parts by weight of persimmon, 15 to 20 parts by weight of persimmon, 5 to 10 parts by weight of a lateral leaf, 5 to 10 parts by weight of a ginkgo leaf, and 5 to 10 parts by weight of a bottle, And 2 to 5 parts by weight of a concentrate of the second group of natural medicines.
여기서 탈모방지 및 발모촉진효과가 더욱 더 향상되도록 포도잎 20 ~ 30중량부, 구아바잎 20 ~ 30중량부, 상엽 20 ~ 30중량부, 비파잎 20 ~ 30중량부로부터 얻은 고형분이 40 ~ 60%인 제3그룹천연약제농축액 1 ~ 3중량부를 더 포함하는 것이 바람직하다.20 to 30 parts by weight of grape leaves, 20 to 30 parts by weight of guava leaves, 20 to 30 parts by weight of upper leaves and 20 to 30 parts by weight of loquat leaves are contained in an amount of 40 to 60% And 1 to 3 parts by weight of the third group natural pharmaceutical concentrate.
한편 상기 목적은 본 발명의 다른 분야에 따라 홍삼의 추출공정 및 홍삼추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 홍삼농축액을 제조하는 홍삼농축액제조단계와; 하수오 10 ~ 20중량부, 영실근 10 ~ 20중량부, 고삼 10 ~ 20중량부, 건지황 5 ~ 15중량부, 당귀 5 ~ 10중량부, 천궁 5 ~ 10중량부, 감초 1 ~ 5중량부(제1그룹천연약제)의 혼합공정, 제1그룹천연약제 혼합물의 추출공정 및 제1그룹천연약제 추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 제1그룹천연약제농축액을 제조하는 제1그룹천연약제농축액제조단계와; 한련초 15 ~ 30중량부, 어성초 15 ~ 30중량부, 구절초 15 ~ 20중량부, 측백엽 5~ 10중량부, 은행잎 5 ~ 10중량부, 병풀잎 5 ~ 10중량부를(제2그룹천연약제)의 혼합공정, 제2그룹천연약제 혼합물의 추출공정 및 제2그룹천연약제 추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 제2그룹천연약제농축액을 제조하는 제2그룹천연약제농축액제조단계와; 상기 홍삼농축액제조단계에서 제조된 홍삼농축액 1중량부와, 상기 제1그룹천연약제농축액제조단계에서 제조된 제1그룹천연약제농축액 4 ~ 5중량부와, 상기 제2그룹천연약제농축액제조단계에서 제조된 제2그룹천연약제농축액 2~ 5중량부를 혼합하는 농축액혼합단계를 포함하는 탈모방지 및 발모촉진용 조성물의 제조방법에 의해 달성된다.The above object of the present invention is also achieved by a method for preparing a red ginseng concentrate, which comprises the steps of extracting red ginseng and concentrating red ginseng extract to prepare a red ginseng concentrate having a solid content of 40 to 60% 10-20 parts by weight of garlic, 10-20 parts by weight of ginseng root, 10-20 parts by weight of ginseng, 5-15 parts by weight of dried ginseng, 5-10 parts by weight of ginseng, 5-10 parts by weight of licorice, 1-5 parts by weight of licorice A first group of natural medicines, a first group of natural medicines, a first group of natural medicines, a first group of natural medicines, and a first group of natural medicines are concentrated to obtain a first group of natural medicinal concentrates having a solid content of 40 to 60% A step of preparing a natural agent concentrate; 15 to 30 parts by weight of Hansikucho, 15 to 30 parts by weight of Rhus herbaceousum, 15 to 20 parts by weight of Rhus herbaceousum, 5 to 10 parts by weight of papaya leaf, 5 to 10 parts by weight of Gingko leaf, and 5 to 10 parts by weight of bottle grass A second group of natural medicines concentrate preparation process for producing a second group of natural medicines concentrate having a solid content of 40 to 60% through a mixing process, an extraction process of the second group of natural medicines mixture and a concentration process of the second group of natural medicament extracts; 1 part by weight of the red ginseng concentrate prepared in the step of preparing the red ginseng concentrate and 4 to 5 parts by weight of the concentrated concentrate of the first group of natural medicaments prepared in the step of preparing the concentrate of the first group natural medicines, And 2 to 5 parts by weight of the concentrate of the second group of natural medicines prepared.
그리고 매실의 향과 홍삼 사포닌의 유효성분을 증대시킬 수 있도록 매실의 추출공정 및 매실추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 매실농축액을 제조하는 매실농축액제조단계를 더 포함하고; 상기 홍삼농축액제조단계는 홍삼추출물 100중량부에 대하여 상기 매실농축액제조단계에서 제조된 매실농축액 0.5 ~ 1중량부를 투입하여 7℃ ~ 8℃에서 12 ~ 24시간 동안 숙성시키는 공정과 상기 숙성공정을 거친 홍삼추출물에 대해 50℃ ~ 60℃에서 30 ~ 40 KHz의 초음파주파수로 20 ~ 30분간 초음파를 조사하는 공정을 홍삼추출물의 농축공정전에 실시하는 것이 바람직하다.And further comprising a step of preparing a plum concentrate to produce a plum concentrate having a solid content of 40 to 60% through an extraction process of plum and a concentrate process of plum extract so as to increase the effective ingredient of the ginseng saponin and the incense of plum; The red ginseng concentrate is prepared by adding 0.5 to 1 part by weight of the plum concentrate prepared in the step of preparing the plum concentrate to 100 parts by weight of the red ginseng extract, aging the mixture at 7 to 8 ° C for 12 to 24 hours, It is preferable to conduct the step of irradiating the red ginseng extract with an ultrasonic wave at an ultrasonic frequency of 30 to 40 KHz at 50 ° C to 60 ° C for 20 to 30 minutes before the concentration process of the red ginseng extract.
따라서 본 발명에 따르면, 홍삼농축액, 제1그룹천연약제농축액(하수오, 영실근, 고삼, 건지황, 당귀, 천궁, 감초) 및 제2그룹천연약제농축액(한련초, 어성초, 구절초, 측백엽, 은행잎, 병풀잎)을 혼합하여 탈모방지 및 발모촉진용 조성물을 제조함으로써, 탈모방지 및 발모촉진효과가 향상된다.Therefore, according to the present invention, it is possible to provide a method for the treatment and / or prevention of diseases caused by red ginseng concentrate, first group natural medicinal concentrate (Hashuo, Youngsil gyu, Gosam, And grass blades) are blended to prepare a composition for preventing hair loss and promoting hair growth, the hair loss prevention and hair growth promoting effect are improved.
도1은 본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물의 제조방법을 도시한 흐름도,
도2는본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물을 사용하기 전 피험자의 모발상태를 찍은 사진,
도3은 본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물을 3주동안 사용한 피험자의 모발상태를 찍은 사진,
도4는 본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물을 5주동안 사용한 피험자의 모발상태를 찍은 사진이다.FIG. 1 is a flow chart showing a method for preparing a composition for preventing hair loss and promoting hair growth according to an embodiment of the present invention,
FIG. 2 is a photograph showing the hair condition of a subject before use of the hair loss prevention and hair growth promoting composition according to the embodiment of the present invention,
FIG. 3 is a photograph showing a hair condition of a subject using a composition for preventing hair loss and promoting hair growth according to an embodiment of the present invention for 3 weeks,
FIG. 4 is a photograph showing a hair condition of a subject using the composition for preventing hair loss and promoting hair growth according to an embodiment of the present invention for 5 weeks. FIG.
이하에서, 첨부도면을 참조하여 본 발명을 상세히 설명하기로 한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.
본 발명에 사용된 천연약제의 일반적인 성상, 약리효과 등은 다음과 같다.The general properties and pharmacological effects of the natural medicines used in the present invention are as follows.
매실(梅實)Plum (plum)
매실(Plum : Prunus mume)은 매화나무의 열매로서, 석신산(succinic acid), 구연산(citric acid), 말산(malic acid), 주석산(tartaric acid) 등의 다양한 유기산뿐만 아니라 시토스테롤(sitosterol)과 무기질 함량이 많은 알칼리성 식품이며, 간기능 회복, 소화촉진, 당뇨병 개선, 항암작용 및 항산화 작용 등의 효과가 있는 것으로 알려져 있다. Plum (Prunus mume) is a fruit of plum tree. It is a fruit of plum tree, and various organic acids such as succinic acid, citric acid, malic acid and tartaric acid as well as sitosterol and mineral It is an alkaline food with high content. It is known to have effects such as recovery of liver function, promotion of digestion, improvement of diabetes, anticancer effect and antioxidant effect.
홍삼(紅蔘)Red ginseng
홈삼은 수삼을 증기 또는 기타 방법으로 쪄서 익혀 말린 것으로써, 면역증강, 심혈관계 조절 및 항암효과 등이 보고되어 있다.Home-grown ginseng is steamed or steamed by other methods, and it is dried and cooked. Immune enhancement, cardiovascular control and anticancer effects have been reported.
그리고 홍삼은 원기를 회복하고, 폐를 튼튼하게 해주며, 비장을 좋게 하고, 심장을 편안하게 해주는 것으로 알려져 있다.And it is known that red ginseng restores the strength, strengthens the lungs, improves the spleen, and comforts the heart.
하수오(何首烏)Hashuo
하수오(Houttuynia cordata)는 간기능을 항진시켜 피로를 적게 하고 피부를 윤택하게 하고, 신장의 기(氣)를 돋우어 탈모증예방 및 양모에 기여하는 것으로 알려져 있다.Houttuynia cordata is known to enhance liver function, to reduce fatigue, to enrich the skin, to promote the kidneys, and to contribute to hair loss prevention and wool.
하오수는 뿌리에 옥시메틸안트라키논(Oxymethylanthraquinone) 유도체들인 크리소파놀(chrysophanol)과 크리소파놀안트론(chrysophanol anthrone), 에모딘(Emodin), 에모딘모노메탈에스테르(Emodinmonometalester) 및 피스시온(physcion), 레시틴(lecithin), 테트라히드록시스틸벤(tetrahydroxystilbene)과 글루코시드(glucoside) 등이 들어 있다.In addition to the oxymethylanthraquinone derivatives chrysophanol and chrysophanol anthrone, emodin, emodinmonometalester and physcion in the root, , Lecithin, tetrahydroxystilbene and glucoside, and the like.
영실근(營實根)Young - Sil Root
영실근(Rosa multiflora roots)은 열을 내리고 습을 거두며 풍을 제거하고 혈액순환을 촉진시킨다.Rosa multiflora roots reduce heat, regenerate moisture, remove wind, and promote blood circulation.
그리고 영실근은 항산화성이 높은 축합형 탄닌화합물(condensed tannins)인 프로시아니딘(procyanidin) B3와 카테킨(catechin)을 포함하고 있다.And Psyllium muscle contains condensation tannins (procyanidin B3 and catechin) which are highly antioxidant.
고삼(苦蔘)Gosam (苦 蔘)
고삼은 인체의 유익한 균을 활성화시키고, 잡균을 없애주는 청결제 역할을 한다. Gosam is a cleansing agent that activates beneficial bacteria of the human body and eliminates germs.
그리고 고삼 추출물은 5a환원효소(5a-reductase)를 저해시켜 양모에도 좋은 효과를 낸다.And the gosam extract inhibits 5a reductase (5a-reductase), which is good for wool.
건지황(乾地黃)Gunjihwang (干 地 黃)
건지황은 지황(Rehmanniae glutinosa) 초본을 건조한 것으로서, 카탈폴(Catalpol), 아큐빈(Acubin), 만니톨(Mannitol), 글루코스(Glucose), 만니노토리오스(Maninotriose), 비타민A 등을 함유한다.Dried Persimmon is a dried herb of Rehmanniae glutinosa and contains Catalpol, Acubin, Mannitol, Glucose, Maninotriose, Vitamin A and others.
그리고 건지황은 혈청에서 과산화지질을 줄이고 수퍼옥시드 디스무타아제 (Superoxide dismutase, SOD, 인체에 해로운 초과산화이온을 산소와 과산화수소로 바꿔줌으로써 독성으로부터 세포를 방어하는 역할을 하는 효소)의 활성을 증가시키는 등의 항산화 및 항노화작용도 한다.In addition, the dried persimmon juice reduces the lipid peroxidation in the serum and increases the activity of superoxide dismutase (SOD), an enzyme that plays a role in protecting cells against toxicity by converting excess oxygen ions, which are harmful to the human body, into oxygen and hydrogen peroxide And also antioxidant and anti-aging function.
당귀(當歸)Angelica (当归)
당귀는 혈을 보하여 주고 청열작용과 혈의 흐름을 좋게 하고, 장의 연동운동을 활발히 해주며 체내의 가스를 원활히 배출시켜 충분한 영양 흡수를 돕는다.Angelica shows blood, improves circulation and blood flow, stimulates intestinal peristalsis, smoothly discharges gas in the body and helps to absorb nutrients.
천궁(川芎)Kangwon
천궁은(Cnidii Rhizoma)을 달인 물에 머리를 감으면 모발에 윤기가 나면서 두피가 깨끗해지며, 발모를 촉진시키는 등의 두피건강에 효과가 있다.When the hair is wrapped around the water of the cnidium rhizoma, the scalp is cleaned with shine on the hair, and it is effective for the scalp health such as promoting the hair growth.
그리고 천궁은 혈액순환을 활발하게 하여 혈류량을 증가시키고 기운의 순행을 도와서 혈압을 내려주는 효능을 가지고 있다. And it has the effect of increasing the blood circulation by activating blood circulation and decreasing the blood pressure by helping the flow of energy.
감초(甘草)Licorice
감초는 독성을 중화시키고, 항균작용, 항산화, 피부 진정, 소염작용, 상처치료와 피부기능의 대사촉진 등의 효과가 있다.Licorice neutralizes toxicity and has effects such as antimicrobial action, antioxidant, skin soothing, anti-inflammatory action, wound treatment and metabolism of skin function.
그리고 감초는 탈모의 원인인 5a환원효소(5a-reductase)를 저해시켜 양모에 좋은 효과를 거두는 것으로 알려져 있다.And licorice is known to inhibit 5a reductase (5a-reductase), which is the cause of hair loss, and to have a good effect on wool.
한련초(旱蓮草)Hansikcho
한련초는 사포님(Saponin), 단백질, 탄닌(Tannin), 비타민 A, 여러 종류의 테레핀(Terpene) 화합물 등을 포함하고 있다.It contains saponin, protein, tannin, vitamin A and various kinds of terpene compounds.
그리고 한련초는 희어진 머리를 검게 하고 수염을 잘 자라게 하므로 대머리 치료약으로 사용된다.And it is used as a baldness remedy because it makes the whitened hair black and grows the beard well.
어성초(漁腥草)Horseshoe
어성초는 강력한 항산화 작용을 하는 천연항생제로서 모낭충의 번식을 억제시키고 염증성 탈모예방에 효과가 있다.It is a natural antibiotic with strong antioxidant activity, which inhibits the growth of the fungus and is effective in preventing inflammation hair loss.
어성초는 소염작용이 뛰어나기 때문에 피부에 생기는 여드름이나 뾰루지 등의 피부트러블 개선에 효과가 있으며, 아토피성 피부염에도 좋다.It is effective for the improvement of skin troubles such as acne and rash caused by skin because it is excellent in anti-inflammatory action, and it is also good for atopic dermatitis.
어성초에 풍부하게 들어 있는 퀘르시트린(quercitrin)이라는 특수성분이 모세혈관을 건강하고 깨끗한 상태로 유지시켜줘 쉽게 멍이 들지 않고 신진대사를 촉진시켜 준다.Quercitrin, which is abundant in herbs, keeps the capillaries healthy and clean, which facilitates metabolism without bruising easily.
또한 어성초는 해독작용이 뛰어나기 때문에 세균감염으로 인한 중금속 및 독 등을 해독하는데 도움을 주며, 몸의 면역력을 키워주고 살균효과로 인해 우리 몸에 유해한 플라보노이드(flavonoid) 성분으로 발생할 수 있는 암이나 염증 등과 같은 질병치료에 뛰어난 효능을 가지고 있다.In addition, Hwasungcho is excellent in detoxification, so it helps to detoxify heavy metals and poison caused by bacterial infection. It also helps to strengthen the body's immune system and to prevent the cancer or inflammation that may occur as a flavonoid component, And the like.
구절초(九節草/ 九折草)Guruscho (九 節 草 / 九 折 草)
구절초는 두통이나 탈모방지에 효과가 있고, 머리가 희게 되는 것을 방지하는 효과가 있으며, 건위, 보익, 강장, 정혈, 식욕촉진, 중풍, 신경통 등에도 효과가 있는 것으로 알려져 있다.It is effective to prevent headache and hair loss, and it is effective to prevent hair from becoming whitened, and it is known that it has effect on the dryness, the biceps, the tongue, the blood circulation, the appetite promotion, the paralysis and the neuralgia.
그리고 구절초에 포함된 콜린(choline) 성분은 뇌에서 기억을 형성하는데 관여하는 화학물질인 아세틸콜린(acetylcholine)의 중요한 기본 구성단위로 신체 각 조직에서 세포막을 형성하는 데 중요한 역할을 하는 것으로 알려지고 있다.In addition, the choline component contained in the vernacellus is an important basic unit of acetylcholine, a chemical substance involved in memory formation in the brain, and is known to play an important role in forming a cell membrane in each body tissue .
측백엽(側柏葉)Lateral leaf
측백엽은 발모의 성장에 중요한 역할을 하는 미리세틴(Myricetin) 성분과 항균성의 히노키티올(hinokitiol) 성분을 갖고 있다.Hyphaeae have myricetin and hinokitiol components that play an important role in the growth of the hairs.
그리고 측백엽은 열을 떨어뜨리기 때문에 맵고 뜨겁고 기름진 음식을 많이 먹거나 과음으로 인한 탈모를 치료해 모발을 검게 하고 모발이 나게 하는 것으로 알려져 있다.And since the leaves are so hot, they eat a lot of hot, hot and fatty foods, and treat hair loss caused by overeating to darken hair and make hair grow.
은행잎Ginkgo leaf
은행잎은 강력한 항산화 작용을 하는 폴리페놀(polyphenols)의 일종인 플라보노이드(flavonids) 성분을 갖고 있어 활성산소종(Reactive oxygen speciecs, ROS)의 작용을 억제하여 심혈관계 질환 및 노화방지, 뇌혈관 증상에 기여하는 것으로 알려져 있다.Ginkgo leaf has a flavonoid component, which is a type of polyphenols that have strong antioxidant activity. It inhibits the action of reactive oxygen species (ROS) and contributes to cardiovascular disease, anti-aging, and cerebral vascular symptoms. .
그리고 은행잎 추출물은 혈액순환과 혈관벽의 탄력성을 좋게하는 작용이 있어, 모근까지 충분히 영양이 전달되는 데 기여한다.And Ginkgo biloba extract has the effect of improving blood circulation and elasticity of blood vessel walls, contributing to nutrient delivery to the hair follicles.
병풀잎Bottle grass
병풀잎은 인체의 콜라겐합성을 조절, 촉진하는 작용을 하는 아시아티코사이드(asiaticoside), 마데코글리코사이드(madecasosside), 아시아틱산(asiatic acid)와 마데카식산(madecassic acid) 성분 등을 포함한다.Bottle grass leaves include asiaticoside, madecasosside, asiatic acid and madecassic acid, which act to control and promote the collagen synthesis of the human body.
그리고 병풀잎은 혈관을 튼튼하게 하여 혈행을 촉진시키며 기억력 향상에도 도움이 되는 것으로 밝혀지고 있다.And Botulinum vulgaris strengthen blood vessels to promote blood circulation and is also found to help improve memory.
포도잎Grape leaves
포도잎에는 세포의 대사과정에서 발생하는 활성산소를 제거하여 노화를 방지하는 폴리페놀성분을 많이 함유하고 있다. The grape leaves contain a large amount of polyphenol compounds that prevent aging by removing active oxygen generated during cellular metabolism.
상엽(桑葉)Mulberry
상엽(뽕잎)은 모세혈관을 튼튼하게 하는 루틴성분과 세포의 대사과정에서 발생하는 활성산소를 제거하여 노화를 방지하는 폴리페놀성분을 많이 함유하고 있다.Mulberry leaves contain a lot of polyphenols that prevent the aging process by removing the active oxygen that arises from the metabolic process of the cell and the routine component that strengthens the capillary blood vessels.
그리고 상엽(뽕잎)은 혈액의 흐름을 좋게 하여 혈관을 튼튼하게 하고 혈압을 안정시켜 주며 장기간 동안 지속적으로 혈압을 낮추어 준다.And mulberry leaves make the blood flow better, strengthen the blood vessels, stabilize the blood pressure and lower the blood pressure continuously for a long time.
구아바잎Guava leaf
구아바(Psidium guajava Linn.) 잎에는 노화의 원인이 되는 과산화 지질의 생성을 억제해 노화를 방지하는 탄닌성분, 세포의 대사과정에서 발생하는 활성산소를 제거하여 노화를 방지하는 폴리페놀성분을 많이 함유하고 있다.Guadaba ( Psidium guajava Linn.) Leaves contain antioxidants that inhibit the formation of lipid peroxidation, which prevents aging, and polyphenols, which prevent aging by removing active oxygen generated during cellular metabolism .
비파잎(枇杷)Loquat leaf (loquat)
비파나무의 잎 즉, 비파잎은 혈액 정화 작용, 혈액순환, 면역력 증강 및 신진대사 등을 촉진하는 작용, 진통작용, 살균작용 및 항암작용을 하는 아미그다린(amygdalin, 비타민 B17)성분, 소염작용, 피로회복을 위한 유기산 및 지방산 대사 촉진 작용을 하는 사포닌성분, 노화의 원인이 되는 과산화 지질의 생성을 억제해 노화를 방지하는 탄닌성분을 많이 함유하고 있다.Leaf of Leek tree, that is, Leek leaf, is an amygdalin (vitamin B17) component that acts to promote blood purification, blood circulation, immunity enhancement and metabolism, analgesic action, , A saponin component that promotes organic acids and fatty acid metabolism for fatigue recovery, and a tannin component that inhibits the generation of lipid peroxidation that causes aging and prevents aging.
본 발명에 따른 탈모방지 및 발모촉진용 조성물을 구성하는 천연약제의 사용부분은 표1과 같다.Table 1 shows the parts of the natural medicines constituting the composition for preventing hair loss and promoting hair growth according to the present invention.
건지황
Dry
하수오
Sewage
감초
licorice
본 발명에 따른 수치임계값의 의미는 다음과 같다.The meaning of the numerical threshold value according to the present invention is as follows.
홍삼농축액, 제1그룹천연약제농축액, 제2그룹천연약제농축액 또는 제3그룹천연약제농축액 중 어느 일방의 고형분이 40%보다 적어지면 목적하는 효과를 얻기 어렵고, 고형분이 60%보다 많아지면 제형이 어려워진다.If the solids content of either the red ginseng concentrate, the first group natural agent concentrate, the second group natural agent concentrate or the third group natural agent concentrate is less than 40%, it is difficult to obtain the desired effect. If the solid content exceeds 60% It gets harder.
매실농축액을 투입하여 홍삼추출물을 숙성시키는 공정에서 숙성시간이 12시간 보다 작으면 숙성이 제대로 되지 않고, 숙성시간이 24시간 보다 많으면 수율이 낮아진다.In the process of aging the red ginseng extract by adding the concentrate of the plum gum, if the aging time is less than 12 hours, the aging is not performed properly. If the aging time is more than 24 hours, the yield is lowered.
숙성된 홍삼추출물에 초음파를 조사하는 공정에서 초음파조사온도가 50℃ 보다 낮으면 목적하는 효과를 얻기 어렵고 초음파조사온도가 60℃ 보다 높으면 초음파의 공동효과에 의한 높은 압력으로 약효성분이 과다하게 파괴될 수 있고, 초음파주파수(에너지)가 30KHz보다 낮거나 초음파조사시간이 20분 보다 작으면 수율이 낮아지고, 초음파주파수가 40KHz 보다 높거나 초음파조사시간이 30분보다 많으면 세포벽의 기공확대로 인해 팽창이 가속화 되어 약리효과가 감소하게 된다.When the ultrasound irradiation temperature is lower than 50 캜 in the step of irradiating the aged ginseng extract with the ultrasound, it is difficult to obtain the desired effect. When the ultrasound irradiation temperature is higher than 60 캜, the high-pressure effect due to the joint effect of ultrasonic waves causes excessive destruction of the active ingredient If the ultrasound frequency (energy) is lower than 30 KHz or the ultrasonic irradiation time is less than 20 minutes, the yield is lowered. If the ultrasonic frequency is higher than 40 KHz or the ultrasonic irradiation time is more than 30 minutes, And the pharmacological effect is reduced.
본 발명의 일 실시예에 따른 탈모방지 및 발모촉진용 조성물의 제조방법을 도1을 참조하여 설명하면 다음과 같다.A method for producing a composition for preventing hair loss and promoting hair growth according to an embodiment of the present invention will be described with reference to FIG.
도1은 본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물의 제조방법을 도시한 흐름도이다.FIG. 1 is a flowchart illustrating a method of manufacturing a composition for preventing hair loss and promoting hair growth according to an embodiment of the present invention.
제조예1(매실농축액의 제조)Production Example 1 (Preparation of a plum concentrate)
먼저 표면에 묻은 이물질과 수분이 제거된 매실을 씨분리기를 사용하여 씨를 분리한다.First, remove the seeds using a seperator to remove the foreign matter and moisture from the surface.
다음에 매실과육을 잘게 파쇄한다.Next, crush the plum finely.
다음에 유압식 착즙기를 이용하여 매실과육으로부터 매실과육즙을 생성한다.Next, using a hydraulic juicer, produce plums and juices from the plum pulp.
다음에 매실과육즙을 농축한다. 여기서 매실과육즙의 농축은 진공저온농축기를 이용하여 고형분이 50%가 되는 매실농축액을 얻도록 실시된다.Next, concentrate the plum and juice. Here, the concentration of the plum and juice is carried out using a vacuum low-temperature concentrator to obtain a plum concentrate having a solid content of 50%.
제조예2(홍삼농축액의 제조)Production Example 2 (Preparation of red ginseng concentrate)
먼저 분쇄기등을 사용하여 건조된 홍삼을 잘게 분쇄하여 분말로 만든다.First, the dried red ginseng is finely pulverized into powder by using a grinder or the like.
다음에 홍삼분말에 추출공정을 실시한다.Next, the red ginseng powder is subjected to an extraction process.
여기서 홍삼분말의 추출공정은 홍삼분말의 중량을 기준으로 10배의 70% 에탄올과 알칼리수의 혼합용매(알칼리수 30% + 에탄올 70%)를 추출용매로 사용하여 2.0kg/㎠ 압력하에서 80℃로 12시간 동안 가열하는 열수추출방법으로 실시한다.Here, the extraction process of red ginseng powder was carried out by using 10 times of a mixed solvent of 70% ethanol and alkaline water (30% of alkaline water + 70% of ethanol) based on the weight of red ginseng powder at 80 kg / This is done by hot water extraction method which is heated for a time.
홍삼추출공정을 후술하는 천연약제와 분리하여 실시하는 것은 홍삼의 사포닌 등 유효성분을 파괴하지 않고 추출효율을 높이기 위하여 추출조건을 달리하기 위함이다.The separation of the red ginseng extraction process from the natural medicament described below is performed in order to differentiate extraction conditions in order to enhance the extraction efficiency without destroying the active ingredient such as saponin of red ginseng.
다음에 홍삼추출물 100중량부를 기준으로 매실농축액 1중량부를 투입하여 8℃에서 15시간 동안 숙성했다. 이와 같이 매실농축액을 투입한 상태에서 홍삼을 숙성시킴으로써, 매실의 향과 홍삼 사포닌의 유효성분을 증대시킬 수 있다.Next, based on 100 parts by weight of the red ginseng extract, 1 part by weight of the plum concentrate was added and aged at 8 DEG C for 15 hours. By thus aging the red ginseng in the state in which the ginseng concentrate is added, the fragrance of the ginseng and the active ingredient of red ginseng saponin can be increased.
다음에 숙성공정을 거친 홍삼추출물을 60℃에서 40 KHz의 초음파주파수로 20분간 조사한다.Next, the red ginseng extract which has been subjected to the aging process is irradiated at 60 ° C at an ultrasonic frequency of 40 KHz for 20 minutes.
다음에 초음파 조사공정을 거친 홍삼의 추출물을 농축한다. 여기서 홍삼추출물의 농축은 200메쉬의 여과장치를 사용하여 여과공정을 거친 후 진공저온농축기를 이용하여 고형분이 50%가 되는 홍삼농축액을 얻도록 실시된다.Next, the extract of red ginseng which has undergone ultrasonic irradiation process is concentrated. Here, the concentration of the red ginseng extract is performed by filtration using a 200-mesh filter apparatus, and then a red ginseng concentrate having a solid content of 50% is obtained using a vacuum low-temperature concentrator.
제조예3(제1그룹천연약제농축액의 제조)Preparation Example 3 (Production of the concentrate of the first group natural medicines)
먼저 이물질과 수분이 제거된 하수오, 영실근, 고삼, 건지황, 당귀, 천궁 및 감초(제1그룹천연약제)를 준비한다.First, prepare dassoo, ginseng, ginseng, ginseng, ginseng, ginseng, and licorice (group 1 natural medicines) with foreign substances and moisture removed.
다음에 하수오 200g, 영실근 200g, 고삼 200g, 건지황 150g, 당귀 100g, 천궁 100g, 감초 50g 비율이 되도록 제1그룹천연약제를 계량한다.Next, the first group of natural medicines are weighed so that the ratio of 200 g of Hasegos, 200 g of Gosil, 200 g of gosam, 150 g of dried ginseng, 100 g of Angelica gigas, 100 g of licorice and 50 g of licorice are obtained.
다음에 분쇄기 등을 사용하여 제1그룹천연약제를 120메쉬크기로 분말화한다.Next, the first group of natural medicines are pulverized to a size of 120 mesh using a pulverizer or the like.
다음에 제1그룹천연약제 분말혼합물에 추출공정을 실시한다.Next, the extraction process is performed on the first group of natural pharmaceutical powder mixtures.
여기서 제1그룹천연약제 분말혼합물의 추출공정은 제1그룹천연약제 분말혼합물의 중량을 기준으로 15배의 알칼리수를 추출용매로 사용하여 2.0kg/㎠ 압력하에서 80℃에서 7시간동안 가열하는 열수추출방법으로 실시한다.Here, the extraction process of the first group of natural drug powder mixture is performed by extracting 15 times of alkaline water based on the weight of the first group of natural drug powder mixture as an extraction solvent, heating it at 80 占 폚 for 7 hours under a pressure of 2.0 kg / .
다음에 제1그룹천연약제 추출물을 농축한다. 여기서 제1그룹천연약제 추출물의 농축은 200메쉬의 여과장치를 사용하여 여과공정을 거친 후 진공저온농축기를 이용하여 고형분이 50%가 되는 제1그룹천연약제농축액을 얻도록 실시된다.Next, the first group natural drug extract is concentrated. Here, the concentration of the first group of natural drug extracts is carried out by filtration using a 200-mesh filtration apparatus, followed by obtaining a concentrate of the first group of natural medicines having a solid content of 50% by using a vacuum low-temperature concentrator.
제조예4(제2그룹천연약제농축액의 제조)Production Example 4 (Production of second group natural pharmaceutical concentrate)
먼저 이물질과 수분이 제거된 한련초, 어성초, 구절초, 측백엽, 은행잎 및 병풀잎(제2그룹천연약제)을 준비한다. First of all, we prepare Hanshikoshi, Hwaseongcho, Kwangsikcho, Hwasobyeol, Ginkgo biloba, and Bottle grass leaf (2nd group natural medicine) which are removed from foreign matter and moisture.
다음에 한련초 250g, 어성초 250g, 구절초 150g, 측백엽 100g, 은행잎 100g 및 병풀잎 100g 비율이 되도록 제2그룹천연약제를 계량한다.Next, the second group of natural medicines are weighed so as to have a ratio of 250g, 250g, 250g, 250g, 100g, 100g, 100g.
다음에 계량된 제2그룹천연약제를 100℃에서 1시간 동안 증숙한다.The second group of natural drugs, then weighed, is boiled for 1 hour at 100 ° C.
다음에 증숙공정을 거친 제2그룹천연약제를 건조시킨다.Next, the second group natural medicines that have been subjected to the steaming process are dried.
다음에 분쇄기 등을 사용하여 건조공정을 거친 제2그룹천연약제를 분쇄하여 120메쉬크기로 분말화한다.Next, the second group of natural medicines that have undergone the drying process using a grinder or the like is pulverized and pulverized to a size of 120 mesh.
다음에 제2그룹천연약제의 분말혼합물에 추출공정을 실시한다.Next, the powder mixture of the second group of natural medicines is subjected to an extraction process.
여기서 제2그룹천연약제 분말혼합물의 추출공정은 제2그룹천연약제 분말혼합물의 중량을 기준으로 15배의 알칼리수를 추출용매로 사용하여 2.0kg/㎠ 압력하에서 90℃에서 5시간동안 가열하는 열수추출방법으로 실시한다.Here, in the extraction process of the second group of natural pharmaceutical powder mixture, 15 times of alkaline water based on the weight of the mixture of the second group of natural pharmaceutical powders is extracted with hot water extraction which is heated at 90 占 폚 for 5 hours under a pressure of 2.0 kg / .
다음에 제2그룹천연약제의 추출물을 농축한다. 여기서 제2그룹천연약제 추출물의 농축공정은 200메쉬의 여과장치를 사용하여 여과공정을 거친 후 진공저온농축기를 이용하여 고형분이 50%가 되는 제2그룹천연약제농축액을 얻도록 실시된다.Next, the extract of the second group of natural medicines is concentrated. Here, the concentration process of the second group of natural drug extracts is carried out by using a 200-mesh filter apparatus to obtain a second group of natural agent concentrates having a solid content of 50% by using a vacuum low-temperature concentrator.
제조예5(제3그룹천연약제농축액의 제조)Production Example 5 (Production of third group natural pharmaceutical concentrate)
먼저 이물질과 수분이 제거된 포도잎, 구아바잎, 상엽 및 비파잎을 준비한다.First, prepare grape leaves, guava leaves, top leaves and loquat leaves with foreign matter and moisture removed.
다음에 포도잎 25중량부, 구아바잎 25중량부, 상엽 25중량부, 비파잎 25중량부 비율이 되도록 제3그룹천연약제를 계량한다.Next, the third group of natural medicines is weighed so as to have a ratio of 25 parts by weight of grape leaves, 25 parts by weight of guava leaves, 25 parts by weight of upper leaves and 25 parts by weight of loquat leaves.
다음에 계량된 제3그룹천연약제를 100℃에서 30분 동안 증숙한다.Next, the third group of natural drugs weighed is boiled for 30 minutes at 100 < 0 > C.
다음에 증숙공정을 거친 제3그룹천연약제를 건조시킨다.Next, the third group natural medicines that have been subjected to the steaming process are dried.
다음에 분쇄기 등을 사용하여 건조공정을 거친 제3그룹천연약제를 분쇄하여 120메쉬크기로 분말화한다. Next, the third group of natural medicines that have undergone the drying process using a pulverizer or the like is pulverized and pulverized to a size of 120 mesh.
다음에 제3그룹천연약제의 분말혼합물에 추출공정을 실시한다.Next, the powder mixture of the third group of natural medicines is subjected to an extraction process.
여기서 제3그룹천연약제 분말혼합물의 추출공정은 제3그룹천연약제 분말혼합물의 중량을 기준으로 20배의 알칼리수를 추출용매로 사용하여 2.0kg/㎠ 압력하에서 90℃에서 3시간동안 가열하는 열수추출방법으로 실시한다.Here, in the extraction process of the third group of natural pharmaceutical powder mixture, 20 times of alkaline water based on the weight of the mixture of the third group of natural pharmaceutical powders is extracted with hot water extraction which is heated at 90 占 폚 for 3 hours under a pressure of 2.0 kg / .
다음에 제3그룹천연약제의 추출물을 농축한다. 여기서 제3그룹천연약제 추출물의 농축공정은 200메쉬의 여과장치를 사용하여 여과공정을 거친 후 진공저온농축기를 이용하여 고형분이 50%가 되는 제3그룹천연약제농축액을 얻도록 실시된다.Next, the extract of the third group of natural medicines is concentrated. Here, the concentration process of the third group natural drug extract is performed by using a 200-mesh filter apparatus to obtain a concentrate of the third group of natural medicines having a solid content of 50% by using a vacuum low-temperature concentrator.
제조예6(농축액의 혼합)Production Example 6 (mixing of concentrated liquid)
먼저 제조예2에서 얻은 홍삼농축액 1중량부, 제조예3에서 얻은 제1그룹천연약제농축액 5중량부, 제조예4에서 얻은 제2그룹천연약제농축액 3중량부, 제조예5에서 얻은 제3그룹천연약제농축액 3중량부의 비율로 배합한다.First, 1 part by weight of the red ginseng concentrate obtained in Preparation Example 2, 5 parts by weight of the first group natural drug concentrate obtained in Preparation Example 3, 3 parts by weight of the second group natural drug concentrate obtained in Preparation Example 4, And 3 parts by weight of the natural drug concentrate.
다음에 배합농축액에 대하여 여과공정(찌꺼기 성분을 걸러내기 위함)과 살균공정을 실시한다.Next, the compound concentrate is subjected to a filtration step (to filter out residue components) and a sterilization step.
다음에 여과공정과 살균공정을 거친 배합농축액을 교반기에 넣고 교반한다.Next, the combined concentrate obtained through the filtration step and the sterilization step is placed in a stirrer and stirred.
한편 전술한 실시예예에서는 추출방법으로는 열수추출을 사용하였으나 에탄올추출, 초음파추출 등을 사용할 수 있다.In the embodiment described above, hot water extraction is used as an extraction method, but ethanol extraction, ultrasonic extraction, and the like can be used.
그리고 전술한 실시예에서는 제1그룹천연약제가 혼합된 상태로 분말화공정을 실시하고 있으나, 제1그룹천연약제를 개별적으로 분말화공정을 실시할 수 있다(하수오에 대해 분말화공정을 실시하고 영실근에 대해 분말화공정을 실시함).In the above-described embodiment, the first group of natural medicines are mixed and powdered, but the first group of natural medicines can be separately pulverized (the powdery process is applied to the sake) The powdery process is performed on the root muscle of the root).
마찬가지로 제2그룹천연약제와 제3그룹천연약제도 개별적으로 분말화공정을 실시할 수 있다.Likewise, the second group natural medicines and the third group natural medicines can be individually subjected to the pulverization process.
본 발명의 탈모방지 및 발모촉진용 조성물은 두피에 직접 도포 또는 산포하는 등의 경피투여에 의해 사용될 수 있으며, 헤어토닉, 헤어로숀, 헤어크림, 샴푸, 린스, 크림, 젤, 패취, 분무제, 연고제 등 다양한 형태로 제형화되어 사용될 수 있다.The composition for preventing hair loss and hair growth of the present invention can be used by transdermal administration such as direct application or spreading on the scalp and can be applied to hair tonic, hair lotion, hair cream, shampoo, rinse, cream, gel, patch, spray, And the like.
제제예1(헤어토닉)Formulation Example 1 (Hair tonic)
본 발명의 탈모방지 및 발모촉진용 조성물에 부형제, 안정제, 보존제, 완충제 등을 첨가하여 표2와 같은 성분을 갖는 헤어토닉을 제조하였다.A hair tonic having the ingredients as shown in Table 2 was prepared by adding an excipient, a stabilizer, a preservative, a buffer, and the like to the hair loss prevention and hair growth promoting composition of the present invention.
제제예1(헤어토닉)에서 보는 바와 같이 천연방부제 역할을 하는 어성초, 은행잎, 감초 등이 첨가 되어 있어 별도의 방부제를 첨가 할 필요가 없다. As shown in Formulation Example 1 (hair tonic), there is no need to add a preservative because it contains natural herbicide, ginkgo leaf, licorice and the like which are natural preservatives.
제제예2(샴푸)Formulation Example 2 (Shampoo)
본 발명의 탈모방지 및 발모촉진용 조성물에 계면활성제, 기포안정제, 보습제, 보존제 등을 첨가하여 표3과 같은 성분을 갖는 샴푸를 제조하였다.A surfactant, a foam stabilizer, a moisturizer, a preservative, and the like were added to the hair loss prevention and hair growth promoting composition of the present invention to prepare a shampoo having the components as shown in Table 3.
본 발명의 탈모방지 및 발모촉진용 조성물의 탈모방지효과 및 발모촉진효과를 확인하기 위해 상기의 제제예1(헤어토닉)과 제제예2(샴푸)를 동시에 사용하여 임상시험을 하였다.In order to confirm the hair loss prevention effect and the hair growth promoting effect of the hair loss prevention and hair growth promoting composition of the present invention, clinical tests were conducted using both formulation example 1 (hair tonic) and formulation example 2 (shampoo) simultaneously.
15명의 탈모 증상이 있는 남자 피험자(평균나이 47세, 발모에 관련되어 영향을 줄 수 있는 국소 도포제나 경구제약을 복용 하는 자 제외)에게 아래와 같이 제제예1(헤어토닉)과 제제예2(샴푸)를 사용하게 하였다.(Hair tonic) and formulation 2 (shampoo) were administered to a male subject with 15 hair loss symptoms (mean age 47 years, except those who were taking topical or oral pharmaceuticals that could affect hair growth) ).
제제예2(샴푸)와 제제예1(헤어토닉)를 동시에 2개월 동안 아침과 저녁(2회/일)에 사용하게 하고, 각 회당 사용방법은 아래와 같다.Formulation Example 2 (shampoo) and Formulation Example 1 (hair tonic) were simultaneously used for 2 months in the morning and evening (twice / day), and the method of using each composition was as follows.
먼저 미지근한 물에 풀어 제제예2(샴푸)를 두발에 적신 후 적당히 마사지한 다음 3 ~ 5분후 물에 헹군 다음 건조한다.First, dissolve in lukewarm water, soak Formulation Example 2 (shampoo) on the hair, massage it appropriately, rinse in water after 3 ~ 5 minutes, and dry.
다음에 제제예1(헤어토닉)을 탈모부위에 약 0.5 ~ 0.75ml씩 점적하고 10 ~ 15초간 두피를 마사지하게 한다.Next, dissolve Formulation Example 1 (hair tonic) at about 0.5 to 0.75 ml at the hair loss site and massage the scalp for 10 to 15 seconds.
피험자에게 알코올 섭취 또는 흡연에 대하여 어떠한 절제나 권장을 하지 않은 상태에서 매주 두피와 모발의 상태를 육안으로 관찰하여 표4와 같은 결과를 얻었다.The subjects were visually observed for weekly scalp and hair condition with no abstinence or recommendation for alcohol consumption or smoking, and the results were as shown in Table 4.
그리고 도2는본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물을 사용하기 전 피험자의 모발상태를 찍은 사진이고 ,도3은 본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물을 3주동안 사용한 피험자의 모발상태를 찍은 사진이고, 도4는 본 발명의 실시예에 따른 탈모방지 및 발모촉진용 조성물을 5주동안 사용한 피험자의 모발상태를 찍은 사진이다.And FIG. 2 is a photograph of a hair condition of a subject before using the hair loss prevention and hair growth promoting composition according to the embodiment of the present invention. FIG. 3 is a photograph showing the hair loss prevention and hair growth promoting composition according to the embodiment of the present invention FIG. 4 is a photograph showing a hair condition of a subject using the composition for preventing hair loss and promoting hair growth according to an embodiment of the present invention for 5 weeks. FIG.
피험자의 80%이상은 사용 2주 후에 두피의 가려움증이 진정 되고 탈모의 진행이 멈추었으며, 사용 3주 후에 두피에 솜털이 나기 시작하면서 빠른 모낭의 성장을 볼 수 있었다.More than 80% of the subjects were able to calm the itchiness of the scalp and stop the progression of hair loss after 2 weeks of use. The hair follicle began to grow on the scalp after 3 weeks of use and showed rapid hair follicle growth.
피험자의 60%이상은 사용 7주 후 소생한 모발이 성장함에 따라 검고 튼튼한 모발이 생겼으며 사용 2개월안에 검은색을 띤 모발의 굵기가 증가함을 알 수 있었다.More than 60% of the subjects had dark and firm hair as the hair revived after 7 weeks of use and increased the thickness of black hair within 2 months of use.
육안적인 판단이지만 본 발명을 통하여 빠른 모낭 성장, 높은 모발의 밀도, 모발의 모양이 곧고 길며 두꺼운 모양으로 변화됨을 알 수 있었다.Although it is the naked eye, it has been found through the present invention that the hair follicle growth, the density of the high hair, and the shape of the hair are changed into a straight, long and thick shape.
위 시험예와 같은 효과는 ① 하수오, 당귀, 은행잎 및 병풀잎 추출물에 의한 혈관확장 및 혈류촉진 효과(모유두 및 모포에의 영양 보급을 원활히 하기 위해 말초혈관의 혈관 확장 효과 및 혈류촉진 효과), ② 천궁 및 상엽의 추출물에 의한 두피 자극작용(두피를 자극하는 것으로 혈관을 확장하고 혈행을 개선할 수 있음), ③어성초 및 건지황 추출물에 의한 피지분비 억제 효과(과산화물질이나 비듬의 발생의 원인이 되는 피지량의 과잉 분비를 억제하고 두피 및 모포주변을 깨끗하게 유지함), ④ 홍삼, 측백엽, 구절초 및 비파잎 추출물에 의한 세포 부활효과(기능이 저하된 모모세포를 부활시켜 발모나 모발의 성장을 촉진함), ⑤ 구아바잎 및 감초 추출물에 의한 영양보급(말소혈관의 순환 장해 등에 의해 기능이 저하된 모모세포에의 영양분으로서 각종 vitamin, 아미노산이 제공됨), ⑥ 영실근, 한련초, 고삼, 포도잎 추출물에 의한 항염증 작용(비듬의 발생이나 외계의 자극 등에 의해 야기된 두피의 염증을 억제하고 건강한 상태로 유지함)에 의해 발휘되는 것으로 평가된다.The same effects as in the above test examples are as follows: (1) vasodilatation and blood flow promoting effect by extracts of Hwasoo, Angelica gigas Nakai, Ginkgo biloba, and Botulinum vulgaris; (vasodilating effect and blood flow promoting effect of peripheral blood vessels in order to facilitate nutrient supply to papillomas and blanket); (Stimulation of the scalp by expanding the blood vessels and improving blood circulation), ③ inhibiting the secretion of sebum by the extracts of Sophora edulis and Sophora edulis (which causes the generation of peroxides and dandruff ④ Reduced cell renewal effect by red ginseng, papaya leaf, perilla leaf and nonpeak leaf extract (promoting hair growth and hair growth by reviving degraded hair cells) , ⑤ nutrient supply by guava leaves and licorice extract (nutrients to monocytes whose function has been impaired by circulatory disturbance of erythrocyte vascular itamin, and amino acids), ⑥ anti-inflammatory action by the extract of grape leaves, hansilikcho, gosam, and grape leaf extract (suppressing the inflammation of the scalp caused by dandruff or external stimulation and keeping it healthy) .
그리고 홍삼추출물의 농축공정전에 홍삼추출물 100중량부에 대하여 매실농축액 0.5 ~ 1중량부를 투입하여 7℃ ~ 8℃에서 12 ~ 24시간 동안 숙성시키는 공정과 숙성공정을 거친 홍삼추출물에 대해 50℃ ~ 60℃에서 30 ~ 40 KHz의 초음파주파수로 20 ~ 30분간 초음파를 조사하는 공정을 실시함으로써, 매실의 향과 홍삼 사포닌의 유효성분을 증대시킬 수 있게 된다.Then, 0.5 to 1 part by weight of the plum concentrate is added to 100 parts by weight of the red ginseng extract before the concentration step, and the red ginseng extract is aged at 7 to 8 ° C for 12 to 24 hours. And the ultrasonic wave is irradiated at an ultrasonic frequency of 30 to 40 KHz for 20 to 30 minutes to increase the fragrance of the plum and the active ingredient of red ginseng saponin.
Claims (5)
하수오 10 ~ 20중량부, 영실근 10 ~ 20중량부, 고삼 10 ~ 20중량부, 건지황 5 ~ 15중량부, 당귀 5 ~ 10중량부, 천궁 5 ~ 10중량부, 감초 1 ~ 5중량부로부터 얻은 고형분이 40 ~ 60%인 제1그룹천연약제농축액 4 ~ 5중량부와;
한련초 15 ~ 30중량부, 어성초 15 ~ 30중량부, 구절초 15 ~ 20중량부, 측백엽 5~ 10중량부, 은행잎 5 ~ 10중량부, 병풀잎 5 ~ 10중량부로부터 얻은 고형분이 40 ~ 60%인 제2그룹천연약제농축액 2~ 5중량부를 포함하는 것을 특징으로 하는 탈모방지 및 발모촉진용 조성물.1 part by weight of a red ginseng concentrate having a solid content of 40 to 60%;
10 to 20 parts by weight of Sasao, 10 to 20 parts by weight of Ganoderma lucidum, 10 to 20 parts by weight of Ganoderma lucidum, 5 to 15 parts by weight of dried ginger, 5 to 10 parts by weight of Ganoderma lucidum, 5 to 10 parts by weight of licorice and 1 to 5 parts by weight of licorice 4 to 5 parts by weight of a concentrated concentrate of the first group of natural medicines having a solid content of 40 to 60%
15 to 30 parts by weight of persimmon, 15 to 30 parts by weight of persimmon, 15 to 20 parts by weight of persimmon, 5 to 10 parts by weight of a lateral leaf, 5 to 10 parts by weight of a ginkgo leaf, and 5 to 10 parts by weight of a bottle, And 2 to 5 parts by weight of a concentrated concentrate of the second group of natural medicines.
포도잎 20 ~ 30중량부, 구아바잎 20 ~ 30중량부, 상엽 20 ~ 30중량부, 비파잎 20 ~ 30중량부로부터 얻은 고형분이 40 ~ 60%인 제3그룹천연약제농축액 1 ~ 3중량부를 더 포함하는 것을 특징으로 하는 탈모방지 및 발모촉진용 조성물.The method according to claim 1,
1 to 3 parts by weight of a concentrate of a third group natural agent having a solid content of 40 to 60% obtained from 20 to 30 parts by weight of grape leaves, 20 to 30 parts by weight of guava leaves, 20 to 30 parts by weight of upper leaves and 20 to 30 parts by weight of loquat leaves The composition for preventing hair loss and promoting hair growth according to claim 1,
하수오 10 ~ 20중량부, 영실근 10 ~ 20중량부, 고삼 10 ~ 20중량부, 건지황 5 ~ 15중량부, 당귀 5 ~ 10중량부, 천궁 5 ~ 10중량부, 감초 1 ~ 5중량부(제1그룹천연약제)의 혼합공정, 제1그룹천연약제 혼합물의 추출공정 및 제1그룹천연약제 추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 제1그룹천연약제농축액을 제조하는 제1그룹천연약제농축액제조단계와;
한련초 15 ~ 30중량부, 어성초 15 ~ 30중량부, 구절초 15 ~ 20중량부, 측백엽 5~ 10중량부, 은행잎 5 ~ 10중량부, 병풀잎 5 ~ 10중량부를(제2그룹천연약제)의 혼합공정, 제2그룹천연약제 혼합물의 추출공정 및 제2그룹천연약제 추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 제2그룹천연약제농축액을 제조하는 제2그룹천연약제농축액제조단계와;
상기 홍삼농축액제조단계에서 제조된 홍삼농축액 1중량부와, 상기 제1그룹천연약제농축액제조단계에서 제조된 제1그룹천연약제농축액 4 ~ 5중량부와, 상기 제2그룹천연약제농축액제조단계에서 제조된 제2그룹천연약제농축액 2~ 5중량부를 혼합하는 농축액혼합단계를 포함하는 탈모방지 및 발모촉진용 조성물의 제조방법.A red ginseng concentrate preparation step of preparing a red ginseng concentrate having a solid content of 40 to 60% through an extraction process of red ginseng and a concentration process of red ginseng extract;
10-20 parts by weight of garlic, 10-20 parts by weight of ginseng root, 10-20 parts by weight of ginseng, 5-15 parts by weight of dried ginseng, 5-10 parts by weight of ginseng, 5-10 parts by weight of licorice, 1-5 parts by weight of licorice A first group of natural medicines, a first group of natural medicines, a first group of natural medicines, a first group of natural medicines, and a first group of natural medicines are concentrated to obtain a first group of natural medicinal concentrates having a solid content of 40 to 60% A step of preparing a natural agent concentrate;
15 to 30 parts by weight of Hansikucho, 15 to 30 parts by weight of Rhus herbaceousum, 15 to 20 parts by weight of Rhus herbaceousum, 5 to 10 parts by weight of papaya leaf, 5 to 10 parts by weight of Gingko leaf, and 5 to 10 parts by weight of bottle grass A second group of natural medicines concentrate preparation process for producing a second group of natural medicines concentrate having a solid content of 40 to 60% through a mixing process, an extraction process of the second group of natural medicines mixture and a concentration process of the second group of natural medicament extracts;
1 part by weight of the red ginseng concentrate prepared in the step of preparing the red ginseng concentrate and 4 to 5 parts by weight of the concentrated concentrate of the first group of natural medicaments prepared in the step of preparing the concentrate of the first group natural medicines, And 2 to 5 parts by weight of the concentrate of the second group of natural medicines prepared.
포도잎 20 ~ 30중량부, 구아바잎 20 ~ 30중량부, 상엽 20 ~ 30중량부, 비파잎 20 ~ 30중량부(제3그룹천연약제)의 혼합공정, 제3그룹천연약제 혼합물의 추출공정 및 제3그룹천연약제 추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 제3그룹천연약제농축액을 제조하는 제3그룹천연약제농축액제조단계를 더 포함하고;
상기 농축액혼합단계는 상기 제3그룹천연약제농축액 1 ~ 3중량부를 함께 혼합하는 것을 특징으로 하는 탈모방지 및 발모촉진용 조성물의 제조방법.The method of claim 3,
20 to 30 parts by weight of grape leaves, 20 to 30 parts by weight of guava leaves, 20 to 30 parts by weight of upper leaves, 20 to 30 parts by weight of loquat leaf (third group natural medicines), extraction process of third group natural medicines mixture And a third group of natural medicament concentrates through a concentration process of the third group natural medicament extract to produce a third group natural medicament concentrate having a solid content of 40 to 60%;
Wherein the concentrate is mixed with 1 to 3 parts by weight of the concentrated concentrate of the third group of natural medicines.
매실의 추출공정 및 매실추출물의 농축공정을 거쳐 고형분이 40 ~ 60%인 매실농축액을 제조하는 매실농축액제조단계를 더 포함하고;
상기 홍삼농축액제조단계는 홍삼추출물 100중량부에 대하여 상기 매실농축액제조단계에서 제조된 매실농축액 0.5 ~ 1중량부를 투입하여 7℃ ~ 8℃에서 12 ~ 24시간 동안 숙성시키는 공정과 상기 숙성공정을 거친 홍삼추출물에 대해 50℃ ~ 60℃에서 30 ~ 40 KHz의 초음파주파수로 20 ~ 30분간 초음파를 조사하는 공정을 홍삼추출물의 농축공정전에 실시하는 것을 특징으로 하는 탈모방지 및 발모촉진용 조성물의 제조방법.The method according to claim 3 or 4,
Further comprising a step of producing a plum concentrate by preparing a plum concentrate having a solid content of 40 to 60% through an extraction process of plum and a concentrating process of plum extract;
The red ginseng concentrate is prepared by adding 0.5 to 1 part by weight of the plum concentrate prepared in the step of preparing the plum concentrate to 100 parts by weight of the red ginseng extract, aging the mixture at 7 to 8 ° C for 12 to 24 hours, A method for preparing a composition for preventing hair loss and promoting hair growth, characterized in that the step of irradiating the red ginseng extract with ultrasonic waves at an ultrasonic frequency of 30 to 40 KHz at 50 ° C to 60 ° C for 20 to 30 minutes is performed before the concentration step of the red ginseng extract .
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150071415A KR101752232B1 (en) | 2015-05-22 | 2015-05-22 | Manufacturing Method of Composition for Hair growth promotion and Hair loss prevention |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020150071415A KR101752232B1 (en) | 2015-05-22 | 2015-05-22 | Manufacturing Method of Composition for Hair growth promotion and Hair loss prevention |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20160136982A true KR20160136982A (en) | 2016-11-30 |
| KR101752232B1 KR101752232B1 (en) | 2017-06-29 |
Family
ID=57707261
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020150071415A Active KR101752232B1 (en) | 2015-05-22 | 2015-05-22 | Manufacturing Method of Composition for Hair growth promotion and Hair loss prevention |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR101752232B1 (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375062A (en) * | 2017-07-12 | 2017-11-24 | 新时代健康产业(集团)有限公司 | A kind of extract containing persimmon without silicone oil shampoo and preparation method thereof |
| KR20180120487A (en) * | 2017-04-27 | 2018-11-06 | 코스맥스 주식회사 | Composition comprising ultrasonic extracts of papaw for improving skin damage |
| KR102316334B1 (en) | 2021-06-16 | 2021-10-22 | 주식회사 프롬바이오 | Food or Cosmetic Composition For Improving Hair Health Containing Complex Natural Product Extract |
| KR20240082692A (en) * | 2022-12-02 | 2024-06-11 | 박준화 | Composition for improving hair condition and preventing hair loss and functioncal shampoo containing the same, and manufacutring method thereof |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102143154B1 (en) * | 2018-10-16 | 2020-08-11 | 홍연희 | Manufacturing method of hair loss prevention shampoo containing graviola component extracted in two steps |
| KR102309913B1 (en) | 2019-11-27 | 2021-10-06 | 한국한의약진흥원 | Composition for improving hangover cure and alcoholic liver injury comprising root extract of Rosa multiflora THUNB |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100818175B1 (en) * | 2007-12-12 | 2008-04-02 | 주식회사 태웅이엘에스 | Hair Treatment Composition |
| KR101049776B1 (en) * | 2011-02-21 | 2011-07-19 | (주)메디웨이코리아 | Hair loss prevention and hair growth cosmetic composition, a preparation method thereof and a composition for hair care containing the same as an active ingredient |
| KR101382203B1 (en) * | 2013-12-23 | 2014-04-07 | 주식회사 닥터스 | Method for production of preventing hair loss and brain waves stabilization composion |
-
2015
- 2015-05-22 KR KR1020150071415A patent/KR101752232B1/en active Active
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180120487A (en) * | 2017-04-27 | 2018-11-06 | 코스맥스 주식회사 | Composition comprising ultrasonic extracts of papaw for improving skin damage |
| CN107375062A (en) * | 2017-07-12 | 2017-11-24 | 新时代健康产业(集团)有限公司 | A kind of extract containing persimmon without silicone oil shampoo and preparation method thereof |
| KR102316334B1 (en) | 2021-06-16 | 2021-10-22 | 주식회사 프롬바이오 | Food or Cosmetic Composition For Improving Hair Health Containing Complex Natural Product Extract |
| KR20240082692A (en) * | 2022-12-02 | 2024-06-11 | 박준화 | Composition for improving hair condition and preventing hair loss and functioncal shampoo containing the same, and manufacutring method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101752232B1 (en) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104825351B (en) | A kind of Lignum Aquilariae Resinatum whitening cleansing facial milk containing and preparation method thereof | |
| KR101373636B1 (en) | Composition for improving condition of skin and scalp containing fermented extracts of herb mixture | |
| KR101752232B1 (en) | Manufacturing Method of Composition for Hair growth promotion and Hair loss prevention | |
| KR101743197B1 (en) | The manufacturing method of shampoo composition for caring scalp and promoting hair growth, and shampoo composition thereof | |
| KR100893106B1 (en) | Composition for hair growth | |
| CN103932970A (en) | Chinese herbal medicine freckle-removal compound cosmetic and preparation method thereof | |
| CN104434618B (en) | Have whitening, nti-freckle concurrently and print nine grass green frosts of effect and preparation method thereof | |
| KR101744103B1 (en) | Composition for preventing hair loss and promoting hair growth and mathod for preparing the same | |
| JP5646117B2 (en) | Hair growth promoter and production method | |
| KR101294762B1 (en) | Functional soap and manufacturing method of it | |
| KR102506318B1 (en) | A method of manufacturing seborrheic scalp inflammation and hair loss relief shampoo and seborrheic scalp inflammation and hair loss relief shampoo prepared thereby | |
| CN105125466A (en) | Freckle removing night cream and preparing method thereof | |
| US7713557B2 (en) | Natural oriental medicinal composition for the promotion of hair growth and method of preparing the same | |
| CN103041042B (en) | Tibetan medicine composition and application of composition in anti-off hair products | |
| CN112370401A (en) | Whitening and skin-brightening composition, preparation method and application thereof | |
| CN109303724A (en) | A kind of novel maintenance stoste composition of releiving containing folium artemisiae argyi | |
| KR101914969B1 (en) | Hair cosmetic composition containing extract of fermented oriental medicinal herbs | |
| CN105147577A (en) | Toner capable of relieving melanin deposition and preparation method of toner | |
| KR20110078559A (en) | Functional cosmetic composition | |
| KR101948597B1 (en) | Hair cosmetic composition with excellent cleansing effect and soothing effect | |
| KR101163069B1 (en) | Cosmetic composition for anti-blemish and anti-wrinkle and method for manufacturing thereof | |
| CN104856920A (en) | Sleep facial mask capable of removing acne marks and preparation method of sleep facial mask | |
| KR101057017B1 (en) | Anti-hair loss soap containing natural extract | |
| CN108403603A (en) | A kind of cherry kaempferia galanga beauty treatment and eliminating spot natural traditional Chinese medicine face mask cream and preparation method thereof | |
| KR102629715B1 (en) | Composition for healthfood comprising vitamins and method for preparing thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20150522 |
|
| PA0201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20161020 Patent event code: PE09021S01D |
|
| PG1501 | Laying open of application | ||
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20170619 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20170623 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20170623 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20200602 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20210527 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20220413 Start annual number: 6 End annual number: 6 |
|
| PR1001 | Payment of annual fee |
Payment date: 20230320 Start annual number: 7 End annual number: 7 |